{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:17:34Z","timestamp":1775002654014,"version":"3.50.1"},"publisher-location":"Cham","reference-count":110,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032041524","type":"print"},{"value":"9783032041531","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-04153-1_22","type":"book-chapter","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:21:38Z","timestamp":1774999298000},"page":"361-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Applications of Pseudoviruses Bearing Glycoproteins of SARS-CoV-2 and Influenza Virus"],"prefix":"10.1007","author":[{"given":"Makoto","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"32","key":"22_CR1","doi-asserted-by":"publisher","first-page":"22237","DOI":"10.1074\/jbc.M114.572974","volume":"289","author":"A Antanasijevic","year":"2014","unstructured":"Antanasijevic A, Basu A, Bowlin TL, Mishra RK, Rong L, Caffrey M (2014) Mutagenesis studies of the H5 influenza hemagglutinin stem loop region. J Biol Chem 289(32):22237\u201322245. https:\/\/doi.org\/10.1074\/jbc.M114.572974","journal-title":"J Biol Chem"},{"issue":"3","key":"22_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10858-016-0025-1","volume":"64","author":"A Antanasijevic","year":"2016","unstructured":"Antanasijevic A, Kingsley C, Basu A, Bowlin TL, Rong L, Caffrey M (2016) Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions. J Biomol NMR 64(3):255\u2013265. https:\/\/doi.org\/10.1007\/s10858-016-0025-1","journal-title":"J Biomol NMR"},{"issue":"5","key":"22_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1021\/acsinfecdis.6b00194","volume":"3","author":"A Basu","year":"2017","unstructured":"Basu A, Komazin-Meredith G, McCarthy C, Antanasijevic A, Cardinale SC, Mishra RK, Barnard DL, Caffrey M, Rong L, Bowlin TL (2017) Molecular mechanism underlying the action of influenza a virus fusion inhibitor MBX2546. ACS Infect Dis 3(5):330\u2013335. https:\/\/doi.org\/10.1021\/acsinfecdis.6b00194","journal-title":"ACS Infect Dis"},{"issue":"11","key":"22_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009743","volume":"17","author":"D Bohan","year":"2021","unstructured":"Bohan D, Van Ert H, Ruggio N, Rogers KJ, Badreddine M, Aguilar Briseno JA, Elliff JM, Rojas Chavez RA, Gao B, Stokowy T, Christakou E, Kursula P, Micklem D, Gausdal G, Haim H, Minna J, Lorens JB, Maury W (2021) Phosphatidylserine receptors enhance SARS-CoV-2 infection. PLoS Pathog 17(11):e1009743. https:\/\/doi.org\/10.1371\/journal.ppat.1009743","journal-title":"PLoS Pathog"},{"issue":"1","key":"22_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/v14010119","volume":"14","author":"SS Borisevich","year":"2022","unstructured":"Borisevich SS, Khamitov EM, Gureev MA, Yarovaya OI, Rudometova NB, Zybkina AV, Mordvinova ED, Shcherbakov DN, Maksyutov RA, Salakhutdinov NF (2022) Simulation of molecular dynamics of SARS-CoV-2 S-protein in the presence of multiple Arbidol molecules: interactions and binding mode insights. Viruses 14(1):119. https:\/\/doi.org\/10.3390\/v14010119","journal-title":"Viruses"},{"issue":"Pt 10","key":"22_CR6","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1099\/0022-1317-82-10-2485","volume":"82","author":"V Bosch","year":"2001","unstructured":"Bosch V, Kramer B, Pfeiffer T, Starck L, Steinhauer DA (2001) Inhibition of release of lentivirus particles with incorporated human influenza virus haemagglutinin by binding to sialic acid-containing cellular receptors. J Gen Virol 82(Pt 10):2485\u20132494. https:\/\/doi.org\/10.1099\/0022-1317-82-10-2485","journal-title":"J Gen Virol"},{"issue":"753","key":"22_CR7","doi-asserted-by":"publisher","first-page":"eado2817","DOI":"10.1126\/scitranslmed.ado2817","volume":"16","author":"Y Cai","year":"2024","unstructured":"Cai Y, Diallo S, Rosenthal K, Ren K, Flores DJ, Dippel A, Oganesyan V, van Dyk N, Chen X, Cantu E, Choudhary R, Sulikowski M, Adissu H, Chawla B, Kar S, Liu C, Dijokaite-Guraliuc A, Mongkolsapaya J, Rajan S, Loo YM, Beavon R, Webber C, Chang LJ, Thomas S, Clegg L, Zhang H, Screaton GR, Philbin N, Harre M, Selim A, Martinez-Alier N, Uriel A, Cohen TS, Perez JL, Esser MT, Blair W, Francica JR (2024a) AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults. Sci Transl Med 16(753):eado2817. https:\/\/doi.org\/10.1126\/scitranslmed.ado2817","journal-title":"Sci Transl Med"},{"issue":"6","key":"22_CR8","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/microorganisms12061201","volume":"12","author":"Z Cai","year":"2024","unstructured":"Cai Z, Kalkeri R, Wang M, Haner B, Dent D, Osman B, Skonieczny P, Ross J, Feng SL, Cai R, Zhu M, Cloney-Clark S, Plested JS (2024b) Validation of a pseudovirus neutralization assay for severe acute respiratory syndrome coronavirus 2: a high-throughput method for the evaluation of vaccine immunogenicity. Microorganisms 12(6):1201. https:\/\/doi.org\/10.3390\/microorganisms12061201","journal-title":"Microorganisms"},{"issue":"7923","key":"22_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao Y, Yisimayi A, Jian F, Song W, Xiao T, Wang L, Du S, Wang J, Li Q, Chen X, Yu Y, Wang P, Zhang Z, Liu P, An R, Hao X, Wang Y, Wang J, Feng R, Sun H, Zhao L, Zhang W, Zhao D, Zheng J, Yu L, Li C, Zhang N, Wang R, Niu X, Yang S, Song X, Chai Y, Hu Y, Shi Y, Zheng L, Li Z, Gu Q, Shao F, Huang W, Jin R, Shen Z, Wang Y, Wang X, Xiao J, Xie XS (2022) BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature 608(7923):593\u2013602. https:\/\/doi.org\/10.1038\/s41586-022-04980-y","journal-title":"Nature"},{"issue":"1","key":"22_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2024.2339703","volume":"15","author":"X Cao","year":"2024","unstructured":"Cao X, Huang L, Tang M, Liang Y, Liu X, Hou H, Liang S (2024) Antibiotics daptomycin interacts with S protein of SARS-CoV-2 to promote cell invasion of Omicron (B1.1.529) pseudovirus. Virulence 15(1):2339703. https:\/\/doi.org\/10.1080\/21505594.2024.2339703","journal-title":"Virulence"},{"issue":"10","key":"22_CR11","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1128\/jvi.74.10.4933-4937.2000","volume":"74","author":"SY Chan","year":"2000","unstructured":"Chan SY, Speck RF, Ma MC, Goldsmith MA (2000) Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 74(10):4933\u20134937. https:\/\/doi.org\/10.1128\/jvi.74.10.4933-4937.2000","journal-title":"J Virol"},{"key":"22_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2023.102638","volume":"55","author":"J Charostad","year":"2023","unstructured":"Charostad J, Rezaei Zadeh Rukerd M, Mahmoudvand S, Bashash D, Hashemi SMA, Nakhaie M, Zandi K (2023) A comprehensive review of highly pathogenic avian influenza (HPAI) H5N1: an imminent threat at doorstep. Travel Med Infect Dis 55:102638. https:\/\/doi.org\/10.1016\/j.tmaid.2023.102638","journal-title":"Travel Med Infect Dis"},{"issue":"6","key":"22_CR13","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.7150\/ijbs.59184","volume":"17","author":"M Chen","year":"2021","unstructured":"Chen M, Zhang XE (2021) Construction and applications of SARS-CoV-2 pseudoviruses: a mini review. Int J Biol Sci 17(6):1574\u20131580. https:\/\/doi.org\/10.7150\/ijbs.59184","journal-title":"Int J Biol Sci"},{"issue":"10","key":"22_CR14","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s00705-014-2127-y","volume":"159","author":"SV Cheresiz","year":"2014","unstructured":"Cheresiz SV, Kononova AA, Razumova YV, Dubich TS, Chepurnov AA, Kushch AA, Davey R, Pokrovsky AG (2014) A vesicular stomatitis pseudovirus expressing the surface glycoproteins of influenza A virus. Arch Virol 159(10):2651\u20132658. https:\/\/doi.org\/10.1007\/s00705-014-2127-y","journal-title":"Arch Virol"},{"key":"22_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.618651","volume":"7","author":"JM Condor Capcha","year":"2020","unstructured":"Condor Capcha JM, Lambert G, Dykxhoorn DM, Salerno AG, Hare JM, Whitt MA, Pahwa S, Jayaweera DT, Shehadeh LA (2020) Generation of SARS-CoV-2 spike pseudotyped virus for viral entry and neutralization assays: a 1-week protocol. Front Cardiovasc Med 7:618651. https:\/\/doi.org\/10.3389\/fcvm.2020.618651","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"22_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3390\/v12050513","volume":"12","author":"KHD Crawford","year":"2020","unstructured":"Crawford KHD, Eguia R, Dingens AS, Loes AN, Malone KD, Wolf CR, Chu HY, Tortorici MA, Veesler D, Murphy M, Pettie D, King NP, Balazs AB, Bloom JD (2020) Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses 12(5):513. https:\/\/doi.org\/10.3390\/v12050513","journal-title":"Viruses"},{"issue":"2","key":"22_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/infdis\/jiaa618","volume":"223","author":"KHD Crawford","year":"2021","unstructured":"Crawford KHD, Dingens AS, Eguia R, Wolf CR, Wilcox N, Logue JK, Shuey K, Casto AM, Fiala B, Wrenn S, Pettie D, King NP, Greninger AL, Chu HY, Bloom JD (2021) Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis 223(2):197\u2013205. https:\/\/doi.org\/10.1093\/infdis\/jiaa618","journal-title":"J Infect Dis"},{"issue":"8021","key":"22_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41586-024-07636-1","volume":"631","author":"B Dadonaite","year":"2024","unstructured":"Dadonaite B, Brown J, McMahon TE, Farrell AG, Figgins MD, Asarnow D, Stewart C, Lee J, Logue J, Bedford T, Murrell B, Chu HY, Veesler D, Bloom JD (2024) Spike deep mutational scanning helps predict success of SARS-CoV-2 clades. Nature 631(8021):617\u2013626. https:\/\/doi.org\/10.1038\/s41586-024-07636-1","journal-title":"Nature"},{"issue":"8013","key":"22_CR19","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41586-024-07385-1","volume":"629","author":"TA Desautels","year":"2024","unstructured":"Desautels TA, Arrildt KT, Zemla AT, Lau EY, Zhu F, Ricci D, Cronin S, Zost SJ, Binshtein E, Scheaffer SM, Dadonaite B, Petersen BK, Engdahl TB, Chen E, Handal LS, Hall L, Goforth JW, Vashchenko D, Nguyen S, Weilhammer DR, Lo JK, Rubinfeld B, Saada EA, Weisenberger T, Lee TH, Whitener B, Case JB, Ladd A, Silva MS, Haluska RM, Grzesiak EA, Earnhart CG, Hopkins S, Bates TW, Thackray LB, Segelke BW, Tri-lab C-C, Lillo AM, Sundaram S, Bloom JD, Diamond MS, Crowe JE Jr, Carnahan RH, Faissol DM (2024) Computationally restoring the potency of a clinical antibody against Omicron. Nature 629(8013):878\u2013885. https:\/\/doi.org\/10.1038\/s41586-024-07385-1","journal-title":"Nature"},{"issue":"3","key":"22_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017821","volume":"6","author":"H Ding","year":"2011","unstructured":"Ding H, Tsai C, Zhou F, Buchy P, Deubel V, Zhou P (2011) Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus. PLoS One 6(3):e17821. https:\/\/doi.org\/10.1371\/journal.pone.0017821","journal-title":"PLoS One"},{"issue":"15","key":"22_CR21","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1128\/JVI.00069-10","volume":"84","author":"N Du","year":"2010","unstructured":"Du N, Zhou J, Lin X, Zhang Y, Yang X, Wang Y, Shu Y (2010) Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol 84(15):7822\u20137831. https:\/\/doi.org\/10.1128\/JVI.00069-10","journal-title":"J Virol"},{"issue":"Pt 8","key":"22_CR22","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1099\/vir.0.80955-0","volume":"86","author":"S Fukushi","year":"2005","unstructured":"Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S (2005) Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol 86(Pt 8):2269\u20132274. https:\/\/doi.org\/10.1099\/vir.0.80955-0","journal-title":"J Gen Virol"},{"issue":"10","key":"22_CR23","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.3390\/v4102097","volume":"4","author":"S Fukushi","year":"2012","unstructured":"Fukushi S, Tani H, Yoshikawa T, Saijo M, Morikawa S (2012) Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers. Viruses 4(10):2097\u20132114. https:\/\/doi.org\/10.3390\/v4102097","journal-title":"Viruses"},{"issue":"2","key":"22_CR24","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/irv.12184","volume":"8","author":"JM Garcia","year":"2014","unstructured":"Garcia JM, Lai JC, Haselhorst T, Choy KT, Yen HL, Peiris JS, von Itzstein M, Nicholls JM (2014) Investigation of the binding and cleavage characteristics of N1 neuraminidases from avian, seasonal, and pandemic influenza viruses using saturation transfer difference nuclear magnetic resonance. Influenza Other Respir Viruses 8(2):235\u2013242. https:\/\/doi.org\/10.1111\/irv.12184","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"22_CR25","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1038\/s41598-021-84850-1","volume":"11","author":"A Goc","year":"2021","unstructured":"Goc A, Niedzwiecki A, Rath M (2021) Polyunsaturated omega-3 fatty acids inhibit ACE2-controlled SARS-CoV-2 binding and cellular entry. Sci Rep 11(1):5207. https:\/\/doi.org\/10.1038\/s41598-021-84850-1","journal-title":"Sci Rep"},{"issue":"6","key":"22_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3390\/v11060507","volume":"11","author":"CA Gonelli","year":"2019","unstructured":"Gonelli CA, Khoury G, Center RJ, Purcell DFJ (2019) HIV-1-based virus-like particles that morphologically resemble mature, infectious HIV-1 virions. Viruses 11(6):507. https:\/\/doi.org\/10.3390\/v11060507","journal-title":"Viruses"},{"issue":"5","key":"22_CR27","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/molecules27051743","volume":"27","author":"P Gonzalez-Maldonado","year":"2022","unstructured":"Gonzalez-Maldonado P, Alvarenga N, Burgos-Edwards A, Flores-Giubi ME, Barua JE, Romero-Rodriguez MC, Soto-Rifo R, Valiente-Echeverria F, Langjahr P, Cantero-Gonzalez G, Sotelo PH (2022) Screening of natural products inhibitors of SARS-CoV-2 entry. Molecules 27(5):1743. https:\/\/doi.org\/10.3390\/molecules27051743","journal-title":"Molecules"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.mex.2015.09.003","volume":"2","author":"K Grehan","year":"2015","unstructured":"Grehan K, Ferrara F, Temperton N (2015) An optimised method for the production of MERS-CoV spike expressing viral pseudotypes. MethodsX 2:379\u2013384. https:\/\/doi.org\/10.1016\/j.mex.2015.09.003","journal-title":"MethodsX"},{"issue":"1","key":"22_CR29","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1038\/s41598-017-03719-4","volume":"7","author":"S Guan","year":"2017","unstructured":"Guan S, Wang T, Kuai Z, Qian M, Tian X, Zhang X, Yu Y, Wang S, Zhang H, Li H, Kong W, Shan Y (2017) Exploration of binding and inhibition mechanism of a small molecule inhibitor of influenza virus H1N1 hemagglutinin by molecular dynamics simulation. Sci Rep 7(1):3786. https:\/\/doi.org\/10.1038\/s41598-017-03719-4","journal-title":"Sci Rep"},{"issue":"10","key":"22_CR30","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1002\/anie.200704872","volume":"47","author":"T Haselhorst","year":"2008","unstructured":"Haselhorst T, Garcia JM, Islam T, Lai JC, Rose FJ, Nicholls JM, Peiris JS, von Itzstein M (2008) Avian influenza H5-containing virus-like particles (VLPs): host-cell receptor specificity by STD NMR spectroscopy. Angew Chem Int Ed Engl 47(10):1910\u20131912. https:\/\/doi.org\/10.1002\/anie.200704872","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"22_CR31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/v15051171","volume":"15","author":"AHE Hassan","year":"2023","unstructured":"Hassan AHE, El-Sayed SM, Yamamoto M, Gohda J, Matsumoto T, Shirouzu M, Inoue JI, Kawaguchi Y, Mansour RMA, Anvari A, Farahat AA (2023) In silico and in vitro evaluation of some amidine derivatives as hit compounds towards development of inhibitors against coronavirus diseases. Viruses 15(5):1171. https:\/\/doi.org\/10.3390\/v15051171","journal-title":"Viruses"},{"issue":"4","key":"22_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1586\/erv.09.8","volume":"8","author":"JR Haynes","year":"2009","unstructured":"Haynes JR (2009) Influenza virus-like particle vaccines. Expert Rev Vaccines 8(4):435\u2013445. https:\/\/doi.org\/10.1586\/erv.09.8","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"22_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.vaccine.2008.11.011","volume":"27","author":"JR Haynes","year":"2009","unstructured":"Haynes JR, Dokken L, Wiley JA, Cawthon AG, Bigger J, Harmsen AG, Richardson C (2009) Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 27(4):530\u2013541. https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.011","journal-title":"Vaccine"},{"issue":"4","key":"22_CR34","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41590-024-01776-2","volume":"25","author":"X He","year":"2024","unstructured":"He X, Zhang X, Wu B, Deng J, Zhang Y, Zhu A, Yuan Y, Lin Y, Chen A, Feng J, Wang X, Wu S, Liu Y, Liu J, Wang Y, Li R, Liang C, Yuan Q, Liang Y, Fang Q, Xi Z, Li W, Liang L, Zhang Z, Tang H, Peng Y, Ke C, Ma X, Cai W, Pan T, Liu B, Deng K, Chen J, Zhao J, Wei X, Chen R, Zhang Y, Zhang H (2024) The receptor binding domain of SARS-CoV-2 Omicron subvariants targets Siglec-9 to decrease its immunogenicity by preventing macrophage phagocytosis. Nat Immunol 25(4):622\u2013632. https:\/\/doi.org\/10.1038\/s41590-024-01776-2","journal-title":"Nat Immunol"},{"issue":"4","key":"22_CR35","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1128\/JVI.02065-07","volume":"82","author":"JW Ho","year":"2008","unstructured":"Ho JW, Hershkovitz O, Peiris M, Zilka A, Bar-Ilan A, Nal B, Chu K, Kudelko M, Kam YW, Achdout H, Mandelboim M, Altmeyer R, Mandelboim O, Bruzzone R, Porgador A (2008) H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol 82(4):2028\u20132032. https:\/\/doi.org\/10.1128\/JVI.02065-07","journal-title":"J Virol"},{"issue":"2","key":"22_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271\u2013280.e278. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"5485","key":"22_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/252743a0","volume":"252","author":"AS Huang","year":"1974","unstructured":"Huang AS, Palma EL, Hewlett N, Roizman B (1974) Pseudotype formation between enveloped RNA and DNA viruses. Nature 252(5485):743\u2013745. https:\/\/doi.org\/10.1038\/252743a0","journal-title":"Nature"},{"issue":"9","key":"22_CR38","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/v12091011","volume":"12","author":"I Hyseni","year":"2020","unstructured":"Hyseni I, Molesti E, Benincasa L, Piu P, Casa E, Temperton NJ, Manenti A, Montomoli E (2020) Characterisation of SARS-CoV-2 lentiviral pseudotypes and correlation between pseudotype-based neutralisation assays and live virus-based micro neutralisation assays. Viruses 12(9):1011. https:\/\/doi.org\/10.3390\/v12091011","journal-title":"Viruses"},{"issue":"15","key":"22_CR39","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.3390\/molecules27154908","volume":"27","author":"H Idriss","year":"2022","unstructured":"Idriss H, Siddig B, Maldonado PG, Elkhair HM, Alakhras AI, Abdallah EM, Torres PHS, Elzupir AO (2022) Phytochemical discrimination, biological activity and molecular docking of water-soluble inhibitors from Saussurea costus herb against main protease of SARS-CoV-2. Molecules 27(15):4908. https:\/\/doi.org\/10.3390\/molecules27154908","journal-title":"Molecules"},{"issue":"1","key":"22_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, Choe H (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 23(1):3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"21","key":"22_CR41","doi-asserted-by":"publisher","first-page":"e01062-20","DOI":"10.1128\/JVI.01062-20","volume":"94","author":"MC Johnson","year":"2020","unstructured":"Johnson MC, Lyddon TD, Suarez R, Salcedo B, LePique M, Graham M, Ricana C, Robinson C, Ritter DG (2020) Optimized pseudotyping conditions for the SARS-COV-2 spike glycoprotein. J Virol 94(21):e01062-20. https:\/\/doi.org\/10.1128\/JVI.01062-20","journal-title":"J Virol"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-3-540-92165-3_14","volume":"333","author":"SM Kang","year":"2009","unstructured":"Kang SM, Pushko P, Bright RA, Smith G, Compans RW (2009) Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 333:269\u2013289. https:\/\/doi.org\/10.1007\/978-3-540-92165-3_14","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"22_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41429-023-00677-0","volume":"77","author":"O Kazakova","year":"2024","unstructured":"Kazakova O, Ma X, Tretyakova E, Smirnova I, Slita A, Sinegubova E, Zarubaev V, Jin H, Zhou D, Xiao S (2024) Evaluation of A-ring hydroxymethylene-amino-triterpenoids as inhibitors of SARS-CoV-2 spike pseudovirus and influenza H1N1. J Antibiot (Tokyo) 77(1):39\u201349. https:\/\/doi.org\/10.1038\/s41429-023-00677-0","journal-title":"J Antibiot (Tokyo)"},{"issue":"3","key":"22_CR44","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/85664","volume":"19","author":"GP Kobinger","year":"2001","unstructured":"Kobinger GP, Weiner DJ, Yu QC, Wilson JM (2001) Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol 19(3):225\u2013230. https:\/\/doi.org\/10.1038\/85664","journal-title":"Nat Biotechnol"},{"issue":"5","key":"22_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/hum.2006.194","volume":"18","author":"GP Kobinger","year":"2007","unstructured":"Kobinger GP, Limberis MP, Somanathan S, Schumer G, Bell P, Wilson JM (2007) Human immunodeficiency viral vector pseudotyped with the spike envelope of severe acute respiratory syndrome coronavirus transduces human airway epithelial cells and dendritic cells. Hum Gene Ther 18(5):413\u2013422. https:\/\/doi.org\/10.1089\/hum.2006.194","journal-title":"Hum Gene Ther"},{"issue":"8","key":"22_CR46","doi-asserted-by":"publisher","first-page":"5982","DOI":"10.1128\/JVI.71.8.5982-5989.1997","volume":"71","author":"E Kretzschmar","year":"1997","unstructured":"Kretzschmar E, Buonocore L, Schnell MJ, Rose JK (1997) High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol 71(8):5982\u20135989. https:\/\/doi.org\/10.1128\/JVI.71.8.5982-5989.1997","journal-title":"J Virol"},{"issue":"10","key":"22_CR47","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","volume":"92","author":"ND Lawson","year":"1995","unstructured":"Lawson ND, Stillman EA, Whitt MA, Rose JK (1995) Recombinant vesicular stomatitis viruses from DNA. Proc Natl Acad Sci USA 92(10):4477\u20134481. https:\/\/doi.org\/10.1073\/pnas.92.10.4477","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"22_CR48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40824-023-00357-y","volume":"27","author":"JE Lee","year":"2023","unstructured":"Lee JE, Jeong SY, Li Z, Kim HY, Kim HW, Yoo MJ, Jang HJ, Kim DK, Cho N, Yoo HM, Kim KH (2023) Development of a screening platform to discover natural products active against SARS-CoV-2 infection using lung organoid models. Biomater Res 27(1):18. https:\/\/doi.org\/10.1186\/s40824-023-00357-y","journal-title":"Biomater Res"},{"issue":"1","key":"22_CR49","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","volume":"11","author":"C Lei","year":"2020","unstructured":"Lei C, Qian K, Li T, Zhang S, Fu W, Ding M, Hu S (2020) Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig. Nat Commun 11(1):2070. https:\/\/doi.org\/10.1038\/s41467-020-16048-4","journal-title":"Nat Commun"},{"issue":"1","key":"22_CR50","doi-asserted-by":"publisher","first-page":"e1963","DOI":"10.1002\/rmv.1963","volume":"28","author":"Q Li","year":"2018","unstructured":"Li Q, Liu Q, Huang W, Li X, Wang Y (2018) Current status on the development of pseudoviruses for enveloped viruses. Rev Med Virol 28(1):e1963. https:\/\/doi.org\/10.1002\/rmv.1963","journal-title":"Rev Med Virol"},{"key":"22_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2020.104600","volume":"143","author":"F Li","year":"2020","unstructured":"Li F, Lu S, Xie X, Fan S, Chen D, Wu S, He J (2020) Antiviral properties of extracts of Streptomyces sp. SMU 03 isolated from the feces of Elephas maximus. Fitoterapia 143:104600. https:\/\/doi.org\/10.1016\/j.fitote.2020.104600","journal-title":"Fitoterapia"},{"key":"22_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105606","volume":"214","author":"Y Li","year":"2023","unstructured":"Li Y, Wang K, Sun H, Wu S, Wang H, Shi Y, Li X, Yan H, Yang G, Wu M, Li Y, Ding X, Si S, Jiang J, Du Y, Li Y, Hong B (2023) Omicsynin B4 potently blocks coronavirus infection by inhibiting host proteases cathepsin L and TMPRSS2. Antivir Res 214:105606. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105606","journal-title":"Antivir Res"},{"issue":"1\u20132","key":"22_CR53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/s0168-1702(01)00407-5","volume":"83","author":"AH Lin","year":"2002","unstructured":"Lin AH, Cannon PM (2002) Use of pseudotyped retroviral vectors to analyze the receptor-binding pocket of hemagglutinin from a pathogenic avian influenza A virus (H7 subtype). Virus Res 83(1\u20132):43\u201356. https:\/\/doi.org\/10.1016\/s0168-1702(01)00407-5","journal-title":"Virus Res"},{"issue":"7","key":"22_CR54","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.3390\/v14071560","volume":"14","author":"KT Liu","year":"2022","unstructured":"Liu KT, Han YJ, Wu GH, Huang KA, Huang PN (2022) Overview of neutralization assays and international standard for detecting SARS-CoV-2 neutralizing antibody. Viruses 14(7):1560. https:\/\/doi.org\/10.3390\/v14071560","journal-title":"Viruses"},{"key":"22_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1365803","volume":"15","author":"S Liu","year":"2024","unstructured":"Liu S, Chen H, Chen X, Luo N, Peraramelli S, Gong X, Zhang MJ, Ou L (2024a) Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection. Front Immunol 15:1365803. https:\/\/doi.org\/10.3389\/fimmu.2024.1365803","journal-title":"Front Immunol"},{"key":"22_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105898","volume":"226","author":"X Liu","year":"2024","unstructured":"Liu X, Wang Y, Sun L, Xiao G, Hou N, Chen J, Wang W, Xu X, Gu Y (2024b) Screening and optimization of shark nanobodies against SARS-CoV-2 spike RBD. Antivir Res 226:105898. https:\/\/doi.org\/10.1016\/j.antiviral.2024.105898","journal-title":"Antivir Res"},{"issue":"5","key":"22_CR57","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s13238-013-2125-y","volume":"4","author":"Y Lu","year":"2013","unstructured":"Lu Y, Jiang T (2013) Pseudovirus-based neuraminidase inhibition assays reveal potential H5N1 drug-resistant mutations. Protein Cell 4(5):356\u2013363. https:\/\/doi.org\/10.1007\/s13238-013-2125-y","journal-title":"Protein Cell"},{"issue":"2","key":"22_CR58","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/v13020156","volume":"13","author":"JM Luczo","year":"2021","unstructured":"Luczo JM, Ronzulli SL, Tompkins SM (2021) Influenza A virus hemagglutinin and other pathogen glycoprotein interactions with NK cell natural cytotoxicity receptors NKp46, NKp44, and NKp30. Viruses 13(2):156. https:\/\/doi.org\/10.3390\/v13020156","journal-title":"Viruses"},{"key":"22_CR59","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/978-1-4614-0980-9_9","volume":"726","author":"M Luo","year":"2012","unstructured":"Luo M (2012) Influenza virus entry. Adv Exp Med Biol 726:201\u2013221. https:\/\/doi.org\/10.1007\/978-1-4614-0980-9_9","journal-title":"Adv Exp Med Biol"},{"key":"22_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1291212","volume":"15","author":"A Maen","year":"2024","unstructured":"Maen A, Gok Yavuz B, Mohamed YI, Esmail A, Lu J, Mohamed A, Azmi AS, Kaseb M, Kasseb O, Li D, Gocio M, Kocak M, Selim A, Ma Q, Kaseb AO (2024) Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection. Front Pharmacol 15:1291212. https:\/\/doi.org\/10.3389\/fphar.2024.1291212","journal-title":"Front Pharmacol"},{"issue":"34","key":"22_CR61","doi-asserted-by":"publisher","first-page":"eaau2710","DOI":"10.1126\/sciimmunol.aau2710","volume":"4","author":"K Matsuda","year":"2019","unstructured":"Matsuda K, Huang J, Zhou T, Sheng Z, Kang BH, Ishida E, Griesman T, Stuccio S, Bolkhovitinov L, Wohlbold TJ, Chromikova V, Cagigi A, Leung K, Andrews S, Cheung CSF, Pullano AA, Plyler J, Soto C, Zhang B, Yang Y, Joyce MG, Tsybovsky Y, Wheatley A, Narpala SR, Guo Y, Darko S, Bailer RT, Poole A, Liang CJ, Smith J, Alexander J, Gurwith M, Migueles SA, Koup RA, Golding H, Khurana S, McDermott AB, Shapiro L, Krammer F, Kwong PD, Connors M (2019) Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine. Sci Immunol 4(34):eaau2710. https:\/\/doi.org\/10.1126\/sciimmunol.aau2710","journal-title":"Sci Immunol"},{"issue":"5","key":"22_CR62","doi-asserted-by":"publisher","first-page":"e140794","DOI":"10.1172\/JCI140794","volume":"131","author":"K Matsuda","year":"2021","unstructured":"Matsuda K, Migueles SA, Huang J, Bolkhovitinov L, Stuccio S, Griesman T, Pullano AA, Kang BH, Ishida E, Zimmerman M, Kashyap N, Martins KM, Stadlbauer D, Pederson J, Patamawenu A, Wright N, Shofner T, Evans S, Liang CJ, Candia J, Biancotto A, Fantoni G, Poole A, Smith J, Alexander J, Gurwith M, Krammer F, Connors M (2021) A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity. J Clin Invest 131(5):e140794. https:\/\/doi.org\/10.1172\/JCI140794","journal-title":"J Clin Invest"},{"issue":"2","key":"22_CR63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1006\/viro.2001.0971","volume":"286","author":"Y Matsuura","year":"2001","unstructured":"Matsuura Y, Tani H, Suzuki K, Kimura-Someya T, Suzuki R, Aizaki H, Ishii K, Moriishi K, Robison CS, Whitt MA, Miyamura T (2001) Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286(2):263\u2013275. https:\/\/doi.org\/10.1006\/viro.2001.0971","journal-title":"Virology"},{"issue":"8","key":"22_CR64","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/sj.gt.3302715","volume":"13","author":"T McKay","year":"2006","unstructured":"McKay T, Patel M, Pickles RJ, Johnson LG, Olsen JC (2006) Influenza M2 envelope protein augments avian influenza hemagglutinin pseudotyping of lentiviral vectors. Gene Ther 13(8):715\u2013724. https:\/\/doi.org\/10.1038\/sj.gt.3302715","journal-title":"Gene Ther"},{"issue":"12","key":"22_CR65","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/jmcb\/mjaa047","volume":"12","author":"K Miyakawa","year":"2020","unstructured":"Miyakawa K, Jeremiah SS, Ohtake N, Matsunaga S, Yamaoka Y, Nishi M, Morita T, Saji R, Nishii M, Kimura H, Hasegawa H, Takeuchi I, Ryo A (2020) Rapid quantitative screening assay for SARS-CoV-2 neutralizing antibodies using HiBiT-tagged virus-like particles. J Mol Cell Biol 12(12):987\u2013990. https:\/\/doi.org\/10.1093\/jmcb\/mjaa047","journal-title":"J Mol Cell Biol"},{"key":"22_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.811004","volume":"9","author":"K Miyakawa","year":"2022","unstructured":"Miyakawa K, Jeremiah SS, Yamaoka Y, Koyama T, Tokumasu R, Kudo M, Kato H, Ryo A (2022) Molecular and epidemiological characterization of emerging immune-escape variants of SARS-CoV-2. Front Med (Lausanne) 9:811004. https:\/\/doi.org\/10.3389\/fmed.2022.811004","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"22_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/infdis\/jiac344","volume":"227","author":"K Miyakawa","year":"2023","unstructured":"Miyakawa K, Kato H, Ohtake N, Jeremiah SS, Ryo A (2023) Enhancement of humoral and cellular immunity against severe acute respiratory syndrome coronavirus 2 by a third dose of BNT162b2 vaccine in Japanese healthcare workers. J Infect Dis 227(2):221\u2013225. https:\/\/doi.org\/10.1093\/infdis\/jiac344","journal-title":"J Infect Dis"},{"issue":"20","key":"22_CR68","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1021\/jm100822f","volume":"53","author":"S Mohan","year":"2010","unstructured":"Mohan S, McAtamney S, Haselhorst T, von Itzstein M, Pinto BM (2010) Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles. J Med Chem 53(20):7377\u20137391. https:\/\/doi.org\/10.1021\/jm100822f","journal-title":"J Med Chem"},{"key":"22_CR69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fimmu.2020.00355","volume":"11","author":"V Murugaiah","year":"2020","unstructured":"Murugaiah V, Varghese PM, Saleh SM, Tsolaki AG, Alrokayan SH, Khan HA, Collison KS, Sim RB, Nal B, Al-Mohanna FA, Kishore U (2020) Complement-independent modulation of influenza a virus infection by factor H. Front Immunol 11:355. https:\/\/doi.org\/10.3389\/fimmu.2020.00355","journal-title":"Front Immunol"},{"issue":"1","key":"22_CR70","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jcv.2007.02.005","volume":"39","author":"I Nefkens","year":"2007","unstructured":"Nefkens I, Garcia JM, Ling CS, Lagarde N, Nicholls J, Tang DJ, Peiris M, Buchy P, Altmeyer R (2007) Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J Clin Virol 39(1):27\u201333. https:\/\/doi.org\/10.1016\/j.jcv.2007.02.005","journal-title":"J Clin Virol"},{"issue":"1","key":"22_CR71","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","volume":"9","author":"J Nie","year":"2020","unstructured":"Nie J, Li Q, Wu J, Zhao C, Hao H, Liu H, Zhang L, Nie L, Qin H, Wang M, Lu Q, Li X, Sun Q, Liu J, Fan C, Huang W, Xu M, Wang Y (2020) Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect 9(1):680\u2013686. https:\/\/doi.org\/10.1080\/22221751.2020.1743767","journal-title":"Emerg Microbes Infect"},{"issue":"1","key":"22_CR72","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1128\/cdli.10.1.154-160.2003","volume":"10","author":"M Ogino","year":"2003","unstructured":"Ogino M, Ebihara H, Lee BH, Araki K, Lundkvist A, Kawaoka Y, Yoshimatsu K, Arikawa J (2003) Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol 10(1):154\u2013160. https:\/\/doi.org\/10.1128\/cdli.10.1.154-160.2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"22_CR73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/1348-0421.13122","volume":"68","author":"T Okura","year":"2024","unstructured":"Okura T, Miyakawa K, Tahara M, Someya K, Seki F, Nishi M, Otsuki N, Ryo A (2024) Rapid quantitative detection system for measles virus-neutralizing antibodies using HiBiT-tagged virus-like particles. Microbiol Immunol 68(4):160\u2013164. https:\/\/doi.org\/10.1111\/1348-0421.13122","journal-title":"Microbiol Immunol"},{"issue":"1","key":"22_CR74","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4269\/ajtmh.13-0151","volume":"90","author":"S Pichyangkul","year":"2014","unstructured":"Pichyangkul S, Krasaesub S, Jongkaewwattana A, Thitithanyanont A, Wiboon-Ut S, Yongvanitchit K, Limsalakpetch A, Kum-Arb U, Mongkolsirichaikul D, Khemnu N, Mahanonda R, Garcia JM, Mason CJ, Walsh DS, Saunders DL (2014) Pre-existing cross-reactive antibodies to avian influenza H5N1 and 2009 pandemic H1N1 in US military personnel. Am J Trop Med Hyg 90(1):149\u2013152. https:\/\/doi.org\/10.4269\/ajtmh.13-0151","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"22_CR75","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/cid\/cir753","volume":"54","author":"C Qiu","year":"2012","unstructured":"Qiu C, Huang Y, Wang Q, Tian D, Zhang W, Hu Y, Yuan Z, Zhang X, Xu J (2012) Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine. Clin Infect Dis 54(1):17\u201324. https:\/\/doi.org\/10.1093\/cid\/cir753","journal-title":"Clin Infect Dis"},{"issue":"1","key":"22_CR76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/vaccines9010013","volume":"9","author":"L Riepler","year":"2020","unstructured":"Riepler L, Rossler A, Falch A, Volland A, Borena W, von Laer D, Kimpel J (2020) Comparison of four SARS-CoV-2 neutralization assays. Vaccines (Basel) 9(1):13. https:\/\/doi.org\/10.3390\/vaccines9010013","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"22_CR77","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00333-23","volume":"11","author":"TL Roe","year":"2023","unstructured":"Roe TL, Brady T, Schuko N, Nguyen A, Beloor J, Guest JD, Aksyuk AA, Tuffy KM, Zhang T, Streicher K, Kelly EJ, Kijak GH (2023) Molecular characterization of AZD7442 (tixagevimab-cilgavimab) neutralization of SARS-CoV-2 Omicron subvariants. Microbiol Spectr 11(2):e0033323. https:\/\/doi.org\/10.1128\/spectrum.00333-23","journal-title":"Microbiol Spectr"},{"issue":"8","key":"22_CR78","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1080\/07391102.2023.2216276","volume":"42","author":"A Romeo","year":"2024","unstructured":"Romeo A, Cappelli G, Iacovelli F, Colizzi V, Falconi M (2024) Computational and experimental validation of phthalocyanine and hypericin as effective SARS-CoV-2 fusion inhibitors. J Biomol Struct Dyn 42(8):3920\u20133934. https:\/\/doi.org\/10.1080\/07391102.2023.2216276","journal-title":"J Biomol Struct Dyn"},{"issue":"22","key":"22_CR79","doi-asserted-by":"publisher","first-page":"eabg7607","DOI":"10.1126\/sciadv.abg7607","volume":"7","author":"A Rosa","year":"2021","unstructured":"Rosa A, Pye VE, Graham C, Muir L, Seow J, Ng KW, Cook NJ, Rees-Spear C, Parker E, Dos Santos MS, Rosadas C, Susana A, Rhys H, Nans A, Masino L, Roustan C, Christodoulou E, Ulferts R, Wrobel AG, Short CE, Fertleman M, Sanders RW, Heaney J, Spyer M, Kjaer S, Riddell A, Malim MH, Beale R, MacRae JI, Taylor GP, Nastouli E, van Gils MJ, Rosenthal PB, Pizzato M, McClure MO, Tedder RS, Kassiotis G, McCoy LE, Doores KJ, Cherepanov P (2021) SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity. Sci Adv 7(22):eabg7607. https:\/\/doi.org\/10.1126\/sciadv.abg7607","journal-title":"Sci Adv"},{"issue":"7990","key":"22_CR80","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41586-023-06761-7","volume":"624","author":"N Saunders","year":"2023","unstructured":"Saunders N, Fernandez I, Planchais C, Michel V, Rajah MM, Baquero Salazar E, Postal J, Porrot F, Guivel-Benhassine F, Blanc C, Chauveau-Le Friec G, Martin A, Grzelak L, Oktavia RM, Meola A, Ahouzi O, Hoover-Watson H, Prot M, Delaune D, Cornelissen M, Deijs M, Meriaux V, Mouquet H, Simon-Loriere E, van der Hoek L, Lafaye P, Rey F, Buchrieser J, Schwartz O (2023) TMPRSS2 is a functional receptor for human coronavirus HKU1. Nature 624(7990):207\u2013214. https:\/\/doi.org\/10.1038\/s41586-023-06761-7","journal-title":"Nature"},{"issue":"8","key":"22_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106192","volume":"9","author":"O Sawoo","year":"2014","unstructured":"Sawoo O, Dublineau A, Batejat C, Zhou P, Manuguerra JC, Leclercq I (2014) Cleavage of hemagglutinin-bearing lentiviral pseudotypes and their use in the study of influenza virus persistence. PLoS One 9(8):e106192. https:\/\/doi.org\/10.1371\/journal.pone.0106192","journal-title":"PLoS One"},{"issue":"11","key":"22_CR82","doi-asserted-by":"publisher","first-page":"e20201181","DOI":"10.1084\/jem.20201181","volume":"217","author":"F Schmidt","year":"2020","unstructured":"Schmidt F, Weisblum Y, Muecksch F, Hoffmann HH, Michailidis E, Lorenzi JCC, Mendoza P, Rutkowska M, Bednarski E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Caskey M, Robbiani DF, Nussenzweig MC, Rice CM, Hatziioannou T, Bieniasz PD (2020) Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med 217(11):e20201181. https:\/\/doi.org\/10.1084\/jem.20201181","journal-title":"J Exp Med"},{"issue":"3","key":"22_CR83","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/v12030304","volume":"12","author":"WZ Shi","year":"2020","unstructured":"Shi WZ, Jiang LZ, Song GP, Wang S, Xiong P, Ke CW (2020) Study on the antiviral activities and hemagglutinin-based molecular mechanism of novel chlorogenin 3-O-beta-chacotrioside derivatives against H5N1 subtype viruses. Viruses 12(3):304. https:\/\/doi.org\/10.3390\/v12030304","journal-title":"Viruses"},{"issue":"9","key":"22_CR84","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0107235","volume":"9","author":"Y Si","year":"2014","unstructured":"Si Y, Li J, Niu Y, Liu X, Ren L, Guo L, Cheng M, Zhou H, Wang J, Jin Q, Yang W (2014) Entry properties and entry inhibitors of a human H7N9 influenza virus. PLoS One 9(9):e107235. https:\/\/doi.org\/10.1371\/journal.pone.0107235","journal-title":"PLoS One"},{"issue":"3","key":"22_CR85","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.antiviral.2008.03.002","volume":"79","author":"CY Su","year":"2008","unstructured":"Su CY, Wang SY, Shie JJ, Jeng KS, Temperton NJ, Fang JM, Wong CH, Cheng YS (2008) In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses. Antivir Res 79(3):199\u2013205. https:\/\/doi.org\/10.1016\/j.antiviral.2008.03.002","journal-title":"Antivir Res"},{"key":"22_CR86","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eng.2021.05.010","volume":"16","author":"H Sun","year":"2022","unstructured":"Sun H, Li X, Chen M, Zhong M, Li Y, Wang K, Du Y, Zhen X, Gao R, Wu Y, Shi Y, Yu L, Che Y, Li Y, Jiang JD, Hong B, Si S (2022) Multi-omics-guided discovery of omicsynins produced by Streptomyces sp. 1647: pseudo-tetrapeptides active against influenza a viruses and coronavirus HCoV-229E. Engineering (Beijing) 16:176\u2013186. https:\/\/doi.org\/10.1016\/j.eng.2021.05.010","journal-title":"Engineering (Beijing)"},{"issue":"11","key":"22_CR87","doi-asserted-by":"publisher","first-page":"6105","DOI":"10.3390\/ijms25116105","volume":"25","author":"LT Tai","year":"2024","unstructured":"Tai LT, Yeh CY, Chang YJ, Liu JF, Hsu KC, Cheng JC, Lu CH (2024) Discovery of novel spike inhibitors against SARS-CoV-2 infection. Int J Mol Sci 25(11):6105. https:\/\/doi.org\/10.3390\/ijms25116105","journal-title":"Int J Mol Sci"},{"issue":"26","key":"22_CR88","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","volume":"94","author":"A Takada","year":"1997","unstructured":"Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y (1997) A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA 94(26):14764\u201314769. https:\/\/doi.org\/10.1073\/pnas.94.26.14764","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"22_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043596","volume":"7","author":"DJ Tang","year":"2012","unstructured":"Tang DJ, Lam YM, Siu YL, Lam CH, Chu SL, Peiris JS, Buchy P, Nal B, Bruzzone R (2012) A single residue substitution in the receptor-binding domain of H5N1 hemagglutinin is critical for packaging into pseudotyped lentiviral particles. PLoS One 7(11):e43596. https:\/\/doi.org\/10.1371\/journal.pone.0043596","journal-title":"PLoS One"},{"issue":"6","key":"22_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107390","volume":"300","author":"X Tang","year":"2024","unstructured":"Tang X, Liu Y, Wang J, Long T, Yee Mok BW, Huang Y, Peng Z, Jia Q, Liu C, So PK, Pui-Kam Tse S, Hei Ng C, Liu S, Sun F, Tang S, Yao ZP, Chen H, Guo Y (2024) Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein. J Biol Chem 300(6):107390. https:\/\/doi.org\/10.1016\/j.jbc.2024.107390","journal-title":"J Biol Chem"},{"issue":"9","key":"22_CR91","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1128\/jvi.74.9.4139-4145.2000","volume":"74","author":"H Tatsuo","year":"2000","unstructured":"Tatsuo H, Okuma K, Tanaka K, Ono N, Minagawa H, Takade A, Matsuura Y, Yanagi Y (2000) Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins. J Virol 74(9):4139\u20134145. https:\/\/doi.org\/10.1128\/jvi.74.9.4139-4145.2000","journal-title":"J Virol"},{"issue":"3","key":"22_CR92","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1750-2659.2007.00016.x","volume":"1","author":"NJ Temperton","year":"2007","unstructured":"Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha DQ, de Jong M, Zambon M, Takeuchi Y, Weiss RA (2007) A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses 1(3):105\u2013112. https:\/\/doi.org\/10.1111\/j.1750-2659.2007.00016.x","journal-title":"Influenza Other Respir Viruses"},{"issue":"10","key":"22_CR93","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.3390\/ijms25105188","volume":"25","author":"P Trischitta","year":"2024","unstructured":"Trischitta P, Tamburello MP, Venuti A, Pennisi R (2024) Pseudovirus-based systems for screening natural antiviral agents: a comprehensive review. Int J Mol Sci 25(10):5188. https:\/\/doi.org\/10.3390\/ijms25105188","journal-title":"Int J Mol Sci"},{"issue":"1","key":"22_CR94","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12929-021-00729-3","volume":"28","author":"SH Tseng","year":"2021","unstructured":"Tseng SH, Lam B, Kung YJ, Lin J, Liu L, Tsai YC, Ferrall L, Roden RBS, Wu TC, Hung CF (2021) A novel pseudovirus-based mouse model of SARS-CoV-2 infection to test COVID-19 interventions. J Biomed Sci 28(1):34. https:\/\/doi.org\/10.1186\/s12929-021-00729-3","journal-title":"J Biomed Sci"},{"issue":"11","key":"22_CR95","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1016\/S1473-3099(23)00575-3","volume":"23","author":"K Uriu","year":"2023","unstructured":"Uriu K, Ito J, Kosugi Y, Tanaka YL, Mugita Y, Guo Z, Hinay AA Jr, Putri O, Kim Y, Shimizu R, Begum MM, Jonathan M, Genotype to Phenotype Japan Consortium, Saito A, Ikeda T, Sato K (2023) Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant. Lancet Infect Dis 23(11):e460\u2013e461. https:\/\/doi.org\/10.1016\/S1473-3099(23)00575-3","journal-title":"Lancet Infect Dis"},{"key":"22_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585361","volume":"11","author":"PM Varghese","year":"2020","unstructured":"Varghese PM, Murugaiah V, Beirag N, Temperton N, Khan HA, Alrokayan SH, Al-Ahdal MN, Nal B, Al-Mohanna FA, Sim RB, Kishore U (2020) C4b binding protein acts as an innate immune effector against influenza A virus. Front Immunol 11:585361. https:\/\/doi.org\/10.3389\/fimmu.2020.585361","journal-title":"Front Immunol"},{"key":"22_CR97","doi-asserted-by":"publisher","first-page":"23011","DOI":"10.3402\/iee.v4.23011","volume":"4","author":"S Wallerstrom","year":"2014","unstructured":"Wallerstrom S, Lagerqvist N, Temperton NJ, Cassmer M, Moreno A, Karlsson M, Leijon M, Lundkvist A, Falk KI (2014) Detection of antibodies against H5 and H7 strains in birds: evaluation of influenza pseudovirus particle neutralization tests. Infect Ecol Epidemiol 4:23011. https:\/\/doi.org\/10.3402\/iee.v4.23011","journal-title":"Infect Ecol Epidemiol"},{"issue":"1","key":"22_CR98","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/1087057113494405","volume":"19","author":"J Wang","year":"2014","unstructured":"Wang J, Cheng H, Ratia K, Varhegyi E, Hendrickson WG, Li J, Rong L (2014) A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses. J Biomol Screen 19(1):100\u2013107. https:\/\/doi.org\/10.1177\/1087057113494405","journal-title":"J Biomol Screen"},{"issue":"7923","key":"22_CR99","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","volume":"608","author":"Q Wang","year":"2022","unstructured":"Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, Wang M, Yu J, Bowen AD, Chang JY, Shah JG, Nguyen N, Chen Z, Meyers K, Yin MT, Sobieszczyk ME, Sheng Z, Huang Y, Liu L, Ho DD (2022) Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature 608(7923):603\u2013608. https:\/\/doi.org\/10.1038\/s41586-022-05053-w","journal-title":"Nature"},{"issue":"18","key":"22_CR100","doi-asserted-by":"publisher","first-page":"8388","DOI":"10.1073\/pnas.92.18.8388","volume":"92","author":"SP Whelan","year":"1995","unstructured":"Whelan SP, Ball LA, Barr JN, Wertz GT (1995) Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci USA 92(18):8388\u20138392. https:\/\/doi.org\/10.1073\/pnas.92.18.8388","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"22_CR101","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","volume":"169","author":"MA Whitt","year":"2010","unstructured":"Whitt MA (2010) Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J Virol Methods 169(2):365\u2013374. https:\/\/doi.org\/10.1016\/j.jviromet.2010.08.006","journal-title":"J Virol Methods"},{"issue":"3","key":"22_CR102","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0092-8674(77)90068-x","volume":"11","author":"ON Witte","year":"1977","unstructured":"Witte ON, Baltimore D (1977) Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus. Cell 11(3):505\u2013511. https:\/\/doi.org\/10.1016\/0092-8674(77)90068-x","journal-title":"Cell"},{"issue":"47","key":"22_CR103","doi-asserted-by":"publisher","first-page":"6387","DOI":"10.1016\/j.vaccine.2017.10.007","volume":"35","author":"J Wu","year":"2017","unstructured":"Wu J, Zhao C, Liu Q, Huang W, Wang Y (2017) Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system. Vaccine 35(47):6387\u20136394. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.007","journal-title":"Vaccine"},{"issue":"1","key":"22_CR104","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1080\/22221751.2020.1815589","volume":"9","author":"HL Xiong","year":"2020","unstructured":"Xiong HL, Wu YT, Cao JL, Yang R, Liu YX, Ma J, Qiao XY, Yao XY, Zhang BH, Zhang YL, Hou WH, Shi Y, Xu JJ, Zhang L, Wang SJ, Fu BR, Yang T, Ge SX, Zhang J, Yuan Q, Huang BY, Li ZY, Zhang TY, Xia NS (2020) Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells. Emerg Microbes Infect 9(1):2105\u20132113. https:\/\/doi.org\/10.1080\/22221751.2020.1815589","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"22_CR105","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00519-22","volume":"13","author":"M Yamamoto","year":"2022","unstructured":"Yamamoto M, Gohda J, Kobayashi A, Tomita K, Hirayama Y, Koshikawa N, Seiki M, Semba K, Akiyama T, Kawaguchi Y, Inoue JI (2022) Metalloproteinase-dependent and TMPRSS2-independent cell surface entry pathway of SARS-CoV-2 requires the furin cleavage site and the S2 domain of spike protein. MBio 13(4):e0051922. https:\/\/doi.org\/10.1128\/mbio.00519-22","journal-title":"MBio"},{"issue":"12","key":"22_CR106","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113629","volume":"9","author":"J Yang","year":"2014","unstructured":"Yang J, Li W, Long Y, Song S, Liu J, Zhang X, Wang X, Jiang S, Liao G (2014) Reliability of pseudotyped influenza viral particles in neutralizing antibody detection. PLoS One 9(12):e113629. https:\/\/doi.org\/10.1371\/journal.pone.0113629","journal-title":"PLoS One"},{"issue":"1","key":"22_CR107","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2343909","volume":"13","author":"S Yang","year":"2024","unstructured":"Yang S, Yu Y, Jian F, Yisimayi A, Song W, Liu J, Wang P, Xu Y, Wang J, Niu X, Yu L, Wang Y, Shao F, Jin R, Wang Y, Cao Y (2024) Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1. Emerg Microbes Infect 13(1):2343909. https:\/\/doi.org\/10.1080\/22221751.2024.2343909","journal-title":"Emerg Microbes Infect"},{"issue":"1\u20132","key":"22_CR108","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jviromet.2008.08.016","volume":"154","author":"S Zhang","year":"2008","unstructured":"Zhang S, Xiao L, Zhou H, Yu Z, Chen H, Guo A, Jin M (2008) Generation and characterization of an H5N1 avian influenza virus hemagglutinin glycoprotein pseudotyped lentivirus. J Virol Methods 154(1\u20132):99\u2013103. https:\/\/doi.org\/10.1016\/j.jviromet.2008.08.016","journal-title":"J Virol Methods"},{"issue":"6","key":"22_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109904","volume":"27","author":"L Zhang","year":"2024","unstructured":"Zhang L, Dopfer-Jablonka A, Cossmann A, Stankov MV, Graichen L, Moldenhauer AS, Fichter C, Aggarwal A, Turville SG, Behrens GMN, Pohlmann S, Hoffmann M (2024) Rapid spread of the SARS-CoV-2 JN.1 lineage is associated with increased neutralization evasion. iScience 27(6):109904. https:\/\/doi.org\/10.1016\/j.isci.2024.109904","journal-title":"iScience"},{"issue":"1","key":"22_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-020-01472-1","volume":"18","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Larragoite ET, Williams E, Lama J, Cisneros I, Delgado JC, Slev P, Rychert J, Innis EA, Coiras M, Rondina MT, Spivak AM, Planelles V (2021) Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions. Virol J 18(1):1. https:\/\/doi.org\/10.1186\/s12985-020-01472-1","journal-title":"Virol J"}],"container-title":["Advances in Experimental Medicine and Biology","The Molecular Immunology of Complex Carbohydrates - 4"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-04153-1_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:21:39Z","timestamp":1774999299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-04153-1_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032041524","9783032041531"],"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-04153-1_22","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}